Insulet Corporation
Clinical trials sponsored by Insulet Corporation, explained in plain language.
A medical device company known for its tubeless insulin pump systems.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Smart insulin pump aims to simplify diabetes management Results expected Dec 2026 (estimated)
- New insulin algorithm aims to simplify diabetes management Results expected Dec 2026 (estimated)
- New insulin pump aims to tame blood sugar swings Results expected Feb 2027 (estimated)
- Thousands to track omnipod 5 in daily life: will the smart pump deliver on its promise? Results expected Jun 2027 (estimated)
- New study puts omnipod 5 to the test in Real-World diabetes management Results expected Jul 2027 (estimated)
-
New insulin algorithm aims to simplify diabetes management
Disease control Recruiting nowThis study tests a next-generation automated insulin delivery system (Omnipod M) in up to 40 adults with type 1 diabetes. The goal is to see if the system safely improves blood sugar control by reducing dangerously low and high levels. Participants will use the device during hote…
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New insulin pump aims to tame blood sugar swings
Disease control Recruiting nowThis study compares a new insulin pump system, Omnipod 6, to the current Omnipod 5 in 200 people with type 1 or type 2 diabetes who have poor blood sugar control. Participants will use both pumps for a set time to see which one helps keep blood sugar in a healthy range more effec…
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Smart insulin pump aims to simplify diabetes management
Disease control Recruiting nowThis study tests a new automatic insulin pump (Omnipod M) in 350 adults with type 2 diabetes who already use insulin. The pump adjusts insulin delivery on its own to keep blood sugar in a healthy range. The goal is to see if it improves blood sugar control and is safe to use.
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New insulin system aims to simplify diabetes management
Disease control Recruiting nowThis study looks at how well the Omnipod 5 Automated Insulin Delivery System works in real-world settings for people with type 1 diabetes. About 152 participants aged 2 and older will use the system for the first time. The goal is to see if it helps keep blood sugar levels in a h…
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Thousands to track omnipod 5 in daily life: will the smart pump deliver on its promise?
Disease control Recruiting nowThis study will follow 2,200 children and adults with type 1 diabetes who are using the Omnipod 5 system, a tubeless insulin pump that automatically adjusts insulin based on continuous glucose monitor readings. Over 12 months, researchers will track how often severe low or high b…
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC